Fedja Rochling is a Gastroenterology physician affiliated with Nebraska Medical Center. OpenAlex indexes 85 publications with 3,469 citations (h-index 17); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
988102 Nebraska Medical Ctr
Omaha, NE 681988102
Telephone
402-559-4015Registry record last updated 23 Jun 2011.
Clinical trials
- Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS)
Sponsor: University of Nebraska
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AbbVie Inc.Program year20211 payment
- Gilead Sciences, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
40.2%Proton pump inhibitor6.4%Pantoprazole Sodium75%Omeprazole25%Part D<11 patientsH2 blocker6%Famotidine100%Part D<11 patients+ 9 more classes in this area
Anti-infectives
17.9%Glycopeptide Antibacterial14%Vancomycin Hcl100%Part D<11 patientsShort-acting sulfonamides2.6%Sulfamethoxazole-Trimethoprim100%Part D<11 patients+ 1 more class in this area
Blood & clotting
16.4%Salt solutions16.4%Sodium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- S3024 Risks of Gastrointestinal Malignancies in Short Bowel Syndrome Patients Treated With Teduglutide: Results From TriNetX
The American Journal of Gastroenterology
2025 - Survival Difference of Colorectal Adenocarcinoma Among Racial and Ethnic Minority Groups: A SEER Database Study
Hawai‘i Journal of Health & Social Welfare
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Andre Kalil, MD
Nebraska Medical Center
Mark Rupp, MD
Nebraska Medical Center
Christopher Kratochvil, MD
Nebraska Medical Center
Dwight Jones, MD
Nebraska Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”